CORMEDIX INC. Supply Commitment, Remaining Minimum Amount Committed
CORMEDIX INC. (CRMD) had Supply Commitment, Remaining Minimum Amount Committed of $4.60 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted · last filed 2025-11-12
- 2025-09-30: Supply Commitment, Remaining Minimum Amount Committed $4.60M.
- 2025-06-30: Supply Commitment, Remaining Minimum Amount Committed $7.80M.
- 2025-03-31: Supply Commitment, Remaining Minimum Amount Committed $9.10M.
- 2024-12-31: Supply Commitment, Remaining Minimum Amount Committed $9.60M.
| Period end | Supply Commitment, Remaining Minimum Amount Committed |
|---|---|
| 2025-09-30 | $4.60M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $7.80M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $9.10M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $9.60M 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |